B1 bradykinin receptor antagonists
The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for treatment of diseases mediated by B1 bradykinin receptor.
Amgen Inc.
C C A A C C A A C A C C A C
C07D C07D A61P A61P C07D C07C A61P A61P C07D A61P C07D C07C A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional
Benny C. Kevin Derin C. Thomas Jian J.
Askew, Jr. Yang D'Amico Nguyen Chen